InvestorsHub Logo
icon url

RockyTen

02/03/17 9:44 AM

#8705 RE: PokerStar #8702

You are the bullshitter. It was not updated until yesterday afternoon. I checked it myself before I posted... I have made mistakes in the past as I ALWAYS admit to but you are full of it. Second...

YOU BETTER GET YOU SOME VDRM BEFORE ALL THE SHARES ARE GONE!!!! Nice news today. More hype and more hope for a half million unit orders! Very nice! I wonder why no money has exchanged hands and VDRM has had to go get their own financing??? Because they have nothing!!!

Buy buy buy!!!! You will be rewarded....at the next drop off to flat line.

Peace. Rocky
icon url

whatarush12

02/03/17 9:44 AM

#8706 RE: PokerStar #8702

PokerStar..what's your take on the news release?
I think once this hits other boards, we fly!!

Orders committed, is just the beginning.
I think this part is huge..

"ViaDerma has also completed an initial clinical study of our proprietary medication for onychomycosis (toenail fungus), and the results were very encouraging with an approximate 80% success rate," said Dr. Otiko.
Onychomycosis affects approximately 5% of the worldwide population. One of the more popular medications on the market has a 17% success rate and can cost as much as $500 per 4ml bottle. Americans currently spend about $1.26 billion annually on oral and topical prescriptions for nail fungus, according to IMS Health, a health care information company. Industry analysts and executives estimate that more effective treatments could expand the market to as much as $3 billion annually.